A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)
Clinical trial NCT07311551 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07311551
- Sponsor
- Bhavya Bhavya, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-24
- Primary completion
- 2026-12-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.